State Street’s HI-TECH PHARMACAL INC HITK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-409,619
Closed -$17.7M 3731
2014
Q1
$17.7M Buy
409,619
+49,223
+14% +$2.13M ﹤0.01% 1872
2013
Q4
$15.6M Buy
360,396
+25,893
+8% +$1.12M ﹤0.01% 1911
2013
Q3
$14.4M Buy
334,503
+81,047
+32% +$3.1M ﹤0.01% 1910
2013
Q2
$8.41M Buy
+253,456
New +$8.44M ﹤0.01% 2155

State Street's HITK Position: Q2 2014 in Review

State Street sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 409,619 shares — an estimated $17.7M sold.

State Street first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $17.7M in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • State Street reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • State Street sold 409,619 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $17.7M.
  • State Street first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • State Street's HI-TECH PHARMACAL INC position peaked at $17.7M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on State Street's 13F filing for Q2 2014, filed 12 Aug 2014.